Intellia Therapeutics (NTLA) Earnings
|
Expand Research on NTLA
| Next EPS Date | 5/2/24 | EPS Growth Rate | -17.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.2% | Revenue Growth Rate | -15.5% |
| Average % Move 1-Wk after EPS | +8.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/22/24 | Q423 | -$1.46 | -$1.44 | -$0.02 | N/A | $12.74M | N/A |  | | Details | |
| 2/27/20 | Q419 | -$0.57 | -$0.56 | -$0.01 | $10.94M | $9.94M | N/A | | | Details | |
| 5/4/23 | Q123 | -$1.17 | -$1.40 | +$0.23 | $12.61M | $11.66M | N/A | | | Details | |
| 5/7/20 |  |
Q120 | -$0.63 | -$0.44 | -$0.19 | $12.92M | $18.14M | N/A | | | Details |
| 5/2/19 | Q119 | -$0.49 | N/A | N/A | $10.43M | $7.47M | N/A | | | Details | |
| 11/5/20 | |
Q320 | -$0.47 | -$0.59 | +$0.12 | $22.22M | $15.58M | N/A | | | Details |
| 8/5/21 | |
Q221 | -$1.01 | -$0.63 | -$0.38 | $6.6M | $11.89M | N/A | | | Details |
| 10/31/19 | |
Q319 | -$0.49 | -$0.62 | +$0.13 | $10.62M | $9.43M | N/A | | | Details |
